Skip to main content
Tea Life Co.,Ltd logo

Tea Life Co.,Ltd — Investor Relations & Filings

Ticker · 3172 ISIN · JP3539050009 T Wholesale and retail trade
Open in API
Filings indexed 69 across all filing types
Latest filing 2026-03-05 Regulatory Filings
Country JP Japan
Listing T 3172

About Tea Life Co.,Ltd

https://www.tealife.co.jp/

Tea Life Co., Ltd. is a company that specializes in the e-commerce and mail-order sales of products supporting health, beauty, and wellness. Its core business involves the development and distribution of healthy teas, health foods, and cosmetics. The company primarily operates through online platforms and catalogs, and also engages in wholesale distribution to other retailers and mail-order businesses. Dedicated to providing total health support, its product lineup includes flagship items such as "Metabo Tea" and "Sukkiri," designed to help customers maintain a healthy lifestyle.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of a previously filed semi-annual report. Per the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS). H1 43
2026-03-05 Japanese
半期報告書－第43期(2025/08/01－2026/07/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed with the Tokai Finance Bureau in Japan. It contains detailed financial statements, including the balance sheet and management analysis for the interim period (2025-08-01 to 2026-01-31). As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. H1 2026
2026-03-05 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act of Japan. It serves as a formal certification by the CEO regarding the accuracy of the Annual Securities Report (Yuuka Shouken Houkokusho). Since it is a regulatory filing required by law to accompany or validate financial reporting and does not fit into specific categories like 10-K or IR, it is classified as a Regulatory Filing. FY 2025
2025-10-23 Japanese
有価証券報告書－第42期(2024/08/01－2025/07/31)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It contains comprehensive financial data, including consolidated financial indicators, balance sheets, and management information for the fiscal year ending July 31, 2025. It is not an announcement or a summary, but the full statutory annual filing. FY 2025
2025-10-23 Japanese
臨時報告書
M&A Activity Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report) and is submitted to the "東海財務局長" (Director of the Tokai Local Finance Bureau) on April 15, 2025. The primary reason for filing is the resolution by the Board of Directors to execute an absorption-type merger (吸収合併) where the company (Tea Life Co., Ltd.) will absorb its wholly-owned subsidiary (株式会社Ｌｉｆｅｉｔ), effective July 1, 2025. This filing explicitly references the requirements of the Financial Instruments and Exchange Act (金融商品取引法) and related Cabinet Office Ordinances (企業内容等の開示に関する内閣府令) for reporting significant corporate actions like the change in a specified subsidiary (特定子会社の異動) and the merger itself. This structure and content strongly indicate a mandatory regulatory filing in Japan concerning a significant corporate event, which aligns best with the general category for such disclosures, especially since it details a merger/acquisition activity (TAR) but is presented as a formal, required disclosure document. However, the content is specifically about a merger (M&A Activity - TAR) and the resulting change in subsidiary status. Since the definitions provided do not have a specific code for a Japanese 'Extraordinary Report' (which often covers M&A, capital changes, etc.), we must choose the closest fit. The document details a takeover/merger proposal (吸収合併), making 'TAR' (M&A Activity) a strong candidate based on the substance. Alternatively, since it is a formal regulatory filing that doesn't fit the specific M&A announcement (TAR) definition perfectly (which usually implies a bid/proposal), 'RNS' (Regulatory Filings - general fallback) is also possible. Given the detailed financial and structural information about the merger partner and the merger terms, 'TAR' is more specific than the general 'RNS'. Revisiting the definitions: TAR is for 'merger proposals or takeover bids'. This document reports the *resolution* to execute the merger, which is a key step in the M&A process. Since the document is a comprehensive report detailing the merger terms, financial data of the target, and rationale, it is more than just a simple announcement (RPA/RNS). Therefore, TAR is the most appropriate classification based on the core subject matter (merger).
2025-04-15 Japanese
確認書
Regulatory Filings
2025-03-04 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.